An interventional study of MouvMat Exergaming and Standard Recreational Programming in Physical Inactivity, Cognitive Decline and Aging, sponsored by University of Toronto. Recruiting at 2 sites in Canada. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-13.
Sponsored by University of Toronto · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 73 studies in Sedentary Behavior with a site in Canada — 18 open to participants now, 19 under way, none of them phase 3. Sedentary Behavior · Canada.
Among the 73 studies in Sedentary Behavior with a site in Canada, this one is the 30th largest by planned enrollment of the 69 interventional ones that give a count, is one of 11 that started in 2022, is one of 67 with no phase, reaches primary completion later than 2 of the 18 other live ones, and was the 38th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →18 of the 73 studies in Sedentary Behavior with a site in Canada are open now. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 50+
University of Alberta · Sites in Canada
Ages 50+
The Royal Ottawa Mental Health Centre · Sites in Canada
Ages 18–75
Nova Scotia Health Authority · Sites in Canada
Ages 65+
Université de Sherbrooke · Sites in Canada
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 55 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
73 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 11 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 50 across the 69 interventional studies, 336 across the 4 observational. Of the 46 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 73 has an industry lead sponsor. The 10 most frequent:
University of Toronto is the lead sponsor of 405 studies on the registry; 51 are open to participants now.
University of Toronto has 9 studies filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
5 of the studies in Sedentary Behavior with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07396857Université de SherbrookeThe Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting | 2026-12-15 |
| NCT06773949The Royal Ottawa Mental Health CentreFeasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression | 2027-01-31 |
| NCT06252259University of British ColumbiaEvaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program | 2027-03 |
| NCT06446414University of British ColumbiaEvaluating Implementation and Impact of Provincial Scale-up of the Adapted Choose to Move (CTM) Program | 2027-04 |
| NCT06345937University of TorontoMultiple Risk Factor Intervention Trial (Ms. FIT) | 2027-08-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 73 studies in Sedentary Behavior with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Residents living in long-term care (LTC) homes spend up to 75% of their day in sedentary, socially withdrawn situations which increases their risk for depression, dementia, decreased functional status and increased care costs. Physical activity is an accepted intervention to improve the physical health, cognition, and well-being of older adults. Moreover, systematic reviews have found that exergaming (i.e. physical activity gamified with technology) offers physical, cognitive, and social benefits by means of dual-task activities that engage both motor and cognitive abilities. The effect of exergaming for older adults in LTC is less clear, as this population has greater health needs related to physical health conditions, cognitive impairment, and functional dependence. Given the increased global demand for LTC, there is a need to develop and assess innovative exergaming technologies that can support the physical and cognitive health of LTC residents.
MouvMat is an exergaming technology intervention with an interactive digital gaming surface designed for older adults (OA) in LTC settings. Participants can play familiar games, like Simon or Bingo, by stepping on or tapping the surface with an assistive pointing device. Games can be played individually or with multiple players. LED lights on the surface provide an adaptive digital display and embedded pressure sensors respond to players' input. The investigators collaboratively designed a preliminary prototype with OA aged 65 and older in a pilot project.
The overall objective of this proposal is to conduct a pilot RCT of the Mouvmat to evaluate the feasibility, acceptability and efficacy of the exergaming technology to improve the primary outcome of mobility, and the secondary outcomes of cognitive function and social isolation compared to a usual care control group receiving standard recreational programming by recreational therapists.
The sample size calculation was completed based on an effect size of 0.65 (power = 0.80; 2-tailed; α= 0.05). Assuming a 5% attrition rate, a total of 56 residents (28 people in a control group and 28 people in the intervention group) will be recruited. A block randomization design using a number generator to conceal the randomization sequence will be used to assign participants' units to the intervention or control groups. Block randomization was conducted to comply with COVID-19 restrictions. The investigators will attempt to recruit equal numbers of men and women with a range of mobility requirements (i.e., ambulate independently, using gait aids such as canes or walkers). In addition, a mix of approximately 5-10 LTC staff and/or residents' family members will be recruited at the end of the trial to conduct semi-structured interviews to understand the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers to exergame technology.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Older adults in the intervention group will participate in a 6-week, 3 times per week, 45 minutes per session exercise program involving use of the MouvMat. Each resident from the intervention group will engage with the exergame supervised by a qualified and trained RA. Each intervention session will involve groups of 4-5 participants, with participants taking turns. An RA blinded to participants' condition will collect the outcome data.
Behavioral: MouvMat Exergaming
A control group will meet on a similar schedule as the MouvMat group for standard recreational programming conducted by onsite recreational therapists. The same RA from the experimental group will collect outcome measurements from control group participants.
Behavioral: Standard Recreational Programming
Sessions engaging with exergaming device.
Conducted by recreational therapists.
Change in mean mobility scores on the Timed-up-and-Go test
Completion time in seconds when participant sits in a standard armchair and is instructed to stand up and walk to a line 3 m away at their normal pace, turn around and sit back down in the chair.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean mobility scores on the Timed-up-and-Go test
Completion time in seconds when participant sits in a standard armchair and is instructed to stand up and walk to a line 3 m away at their normal pace, turn around and sit back down in the chair.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean mobility scores on the 2-Minute Walk Test
Distance walked in meters when a participant is instructed to walk at the fastest speed that they can for 2 minutes.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean mobility scores on the 2-Minute Walk Test
Distance walked in meters when a participant is instructed to walk at the fastest speed that they can for 2 minutes.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Adverse events (e.g. injury) related to exergame use
Number of adverse events related to use of the exergame in the intervention group
Time frame: Over the course of the intervention (baseline to 6 weeks)
Feasibility related to adherence rate
Mean percentage of sessions attended in the intervention group (i.e., number of sessions attended / total scheduled sessions)
Time frame: Over the course of the intervention (baseline to 6 weeks)
Change in mean working memory scores on digit span
Total scores for the WAIS-III forward and backward digit span, in which participants are asked to repeat a series of digits that are read by an experimenter in the same order (forward) or reverse order (backward).
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean working memory scores on digit span
Total scores for the WAIS-III forward and backward digit span, in which participants are asked to repeat a series of digits that are read by an experimenter in the same order (forward) or reverse order (backward).
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean basic attention/psychomotor speed on the Trail Making Test A
Time to completion in seconds on a task requiring connecting numbered dots on a page in order as quickly as possible.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean basic attention/psychomotor speed on the Trail Making Test A
Time to completion in seconds on a task requiring connecting numbered dots on a page in order as quickly as possible.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean alternating attention scores on the Trail Making Test B
Time to completion in seconds on a task requiring switching between connecting numbers and letters in dots on a page as quickly as possible.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean alternating attention scores on the Trail Making Test B
Time to completion in seconds on a task requiring switching between connecting numbers and letters in dots on a page as quickly as possible.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in errors made on an alternating sequences test
Number of errors made on a task requiring alternating between drawing two designs. This test is sensitive to cognitive problems with executive functions including inhibition and perseveration.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in errors made on an alternating sequences test
Number of errors made on a task requiring alternating between drawing two designs. This test is sensitive to cognitive problems with executive functions including inhibition and perseveration.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean verbal fluency scores
Number of words generated in one minute given a letter cue
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean verbal fluency scores
Number of words generated in one minute given a letter cue
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean scores for social isolation assessed by UCLA Loneliness Scale 3
Total score on a 20-item questionnaire that assesses how often a person feels lonely and isolated from others.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean scores for social isolation assessed by UCLA Loneliness Scale 3
Total score on a 20-item questionnaire that assesses how often a person feels lonely and isolated from others.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Change in mean scores on the Cornell Scale for Depression in Dementia
Total scores on a measure based on interviews on 19 items related to depression.
Time frame: Baseline and mid-point of the intervention (3 weeks)
Change in mean scores on the Cornell Scale for Depression in Dementia
Total scores on a measure based on interviews on 19 items related to depression.
Time frame: Baseline and following the completion of the intervention (6 weeks)
Acceptability on a version of the modified Treatment Evaluation Inventory (m-TEI) adapted for exergame use
Mean total score from intervention group participants and family members/staff
Time frame: Following the completion of the intervention (6 weeks)
Semi-structured interviews to evaluate the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers
A semi-structured interview will be completed with residents in the intervention group, as well as stakeholders including family members and staff, with questions designed to understand the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers to exergame technology. The post-intervention interviews will be analyzed using thematic analysis.
Time frame: Following the completion of the intervention (6 weeks)
Started Oct 2022 (actual). Primary completion is estimated for Jan 2025, 27 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 27 months is above that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.